P118: Two Cases of Angiocentric Glioma with MYB::QKI Fusion in a Single Institution

Deepak Kumar,Fnu Kiran,Melissa Gener,Alexander Kats,Lei Zhang
DOI: https://doi.org/10.1016/j.gimo.2024.100999
2024-01-01
Genetics in Medicine Open
Abstract:Angiocentric glioma (AG) is a rare diffuse low-grade glioma typically found in the cerebral hemispheres with limited data on its occurrence in a specific age or race population. Histologically, this tumor may share features with other low grade glial neoplasms. MYB::QKI gene fusion was recently identified as the defining genetic alteration in the majority of AGs. Only an accountable number of AGs with MYB::QKI fusion has been reported so far. We present two AG cases of 15- and 11-year-old females encountered in a single institution in 2017 and 2023. Histopathology examination, immunohistochemistry, karyotyping and chromosomal microarray analysis were performed. Histopathology interpretation was performed by at least two separate pathologists, and one of the cases additionally underwent an expert review. The association of MYB rearrangement with AG was reviewed. Both patients presented predominantly with worsening headaches. The brain MRI revealed a 2.6 cm mass involving the left posterior temporal lobe in one patient, and a 4.7 cm posterior fossa mass arising from the right cerebral peduncle with resultant obstructive hydrocephalus in another patient. Radiological differentials included dysembryoplastic neuroepithelial tumor and pleomorphic xanthoastrocytoma. Both patients underwent resection of their tumors. Histopathology in one case showed scattered dysplastic neurons and rind-like proliferation of spindle-shaped meningioepithelial cells with tongue-like projections in a perivascular pattern. The lesional cells were strongly positive for GFAP and patchy weak positivity for EMA. NFP was negative. NeuN highlighted mature and a few dysplastic neurons. Ki-67 was 2-4%. Histology in the second case revealed infiltrative small astrocytic cells with focal myxoid background. Ki-67 was positive in <5% of tumor cell nuclei. Tumor cells were diffusely positive for GFAP and Olig2 and negative for IDH1, P53, H3K27M, or BRAFV600E. Both tumors lacked high-grade histologic features. Microarray analysis revealed an ∼28 Mb interstitial deletion from 6q23.3 to 6q26 resulting in MYB::QKI fusion in both cases. Chromosome analysis was successfully performed on one case and confirms 6q deletion. The integrated diagnosis for both cases was angiocentric glioma. These two AG cases show similar age, location and morphology as those previously reported with MYB::QKI fusion, thus further confirmed the diagnostic value of MYB::QKI fusion for this rare entity.
What problem does this paper attempt to address?